Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002088110 - QUINOLINE DERIVATIVE HAVING AZOLYL GROUP AND QUINAZOLINE DERIVATIVE

Publication Number WO/2002/088110
Publication Date 07.11.2002
International Application No. PCT/JP2002/004279
International Filing Date 26.04.2002
Chapter 2 Demand Filed 26.04.2002
IPC
C07D 413/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
413Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
CPC
A61P 17/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17Drugs for dermatological disorders
06Antipsoriatics
A61P 19/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
19Drugs for skeletal disorders
02for joint disorders, e.g. arthritis, arthrosis
A61P 27/02
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
27Drugs for disorders of the senses
02Ophthalmic agents
A61P 29/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
29Non-central analgesic, antipyretic or anti-inflammatory agents, e.g antirheumatic agents; Non-steroidal anti-inflammatory drugs (NSAIDs)
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • KIRIN BEER KABUSHIKI KAISHA [JP]/[JP] (AllExceptUS)
  • KUBO, Kazuo [JP]/[JP] (UsOnly)
  • SAKAI, Teruyuki [JP]/[JP] (UsOnly)
  • NAGAO, Rika [JP]/[JP] (UsOnly)
  • FUJIWARA, Yasunari [JP]/[JP] (UsOnly)
  • ISOE, Toshiyuki [JP]/[JP] (UsOnly)
  • HASEGAWA, Kazumasa [JP]/[JP] (UsOnly)
Inventors
  • KUBO, Kazuo
  • SAKAI, Teruyuki
  • NAGAO, Rika
  • FUJIWARA, Yasunari
  • ISOE, Toshiyuki
  • HASEGAWA, Kazumasa
Agents
  • YOSHITAKE, Kenji
Priority Data
2001-13277527.04.2001JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) QUINOLINE DERIVATIVE HAVING AZOLYL GROUP AND QUINAZOLINE DERIVATIVE
(FR) DERIVES DE QUINOLINE AYANT UN GROUPE AZOLYLE ET DERIVES DE QUINAZOLINE
Abstract
(EN)
A compound having strong antitumor activity. It is a compound represented by the formula (I) or a pharmaceutically acceptable salt or solvate thereof: (I) wherein X and Z each represents CH or nitrogen; Y represents oxygen or sulfur; R1, R2, and R3 each represents hydrogen, alkoxy, etc.; R4 represents hydrogen; R5, R6, R7, and R8 each represents hydrogen, halogeno, alkoxy, etc.; R9 and R10 each represents hydrogen, alkyl, etc.; and R11 represents optionally substituted azolyl.
(FR)
L'invention concerne un composé ayant une forte activité antitumorale. C'est un composé représenté par la formule (I) ou un sel ou solvate pharmaceutiquement acceptable de ce dernier. Dans la formule (I), X et Z représentent respectivement CH ou azote ; Y représente oxygène ou soufre ; R1, R2 et R3 représentent respectivement hydrogène, alcoxy etc. ; R4 représente hydrogène ; R5, R6, R7 et R8 représentent respectivement hydrogène, halogène, alcoxy etc. ; R9 et R10 représentent respectivement hydrogène, alkyle etc. ; et R11 représentent un azolyle éventuellement substitué.
Latest bibliographic data on file with the International Bureau